Marwan Tabbara1, Juan C Duque1, Laisel Martinez1, Luis A Escobar1, Wensong Wu2, Yue Pan3, Natasha Fernandez1, Omaida C Velazquez1, Edgar A Jaimes4, Loay H Salman5, Roberto I Vazquez-Padron6. 1. DeWitt Daughtry Family Department of Surgery, Leonard M. Miller School of Medicine, University of Miami, Miami, FL. 2. Department of Mathematics and Statistics, Florida International University, Miami, FL. 3. Department of Epidemiology and Public Health, University of Miami, Coral Gables, FL. 4. Renal Service, Memorial Sloan Kettering Cancer Center, New York, NY. 5. Section of Interventional Nephrology, Leonard M. Miller School of Medicine, University of Miami, Miami, FL. 6. DeWitt Daughtry Family Department of Surgery, Leonard M. Miller School of Medicine, University of Miami, Miami, FL. Electronic address: rvazquez@med.miami.edu.
Abstract
BACKGROUND: The contribution of intimal hyperplasia (IH) to arteriovenous fistula (AVF) failure is uncertain. This observational study assessed the relationship between pre-existing, postoperative, and change in IH over time and AVF outcomes. STUDY DESIGN: Prospective cohort study with longitudinal assessment of IH at the time of AVF creation (pre-existing) and transposition (postoperative). Patients were followed up for up to 3.3 years. SETTING & PARTICIPANTS: 96 patients from a single center who underwent AVF surgery initially planned as a 2-stage procedure. Veins and AVF samples were collected from 66 and 86 patients, respectively. Matched-pair tissues were available from 56 of these patients. PREDICTORS: Pre-existing, postoperative, and change in IH over time. OUTCOMES: Anatomic maturation failure was defined as an AVF that never reached a diameter > 6mm. Primary unassisted patency was defined as the time elapsed from the second-stage surgery to the first intervention. MEASUREMENTS: Maximal intimal thickness in veins and AVFs and change in intimal thickness over time. RESULTS: Pre-existing IH (>0.05mm) was present in 98% of patients. In this group, the median intimal thickness increased 4.40-fold (IQR, 2.17- to 4.94-fold) between AVF creation and transposition. However, this change was not associated with pre-existing thickness (r(2)=0.002; P=0.7). Ten of 96 (10%) AVFs never achieved maturation, whereas 70% of vascular accesses remained patent at the end of the observational period. Postoperative IH was not associated with anatomic maturation failure using univariate logistic regression. Pre-existing, postoperative, and change in IH over time had no effects on primary unassisted patency. LIMITATIONS: The small number of patients from whom longitudinal tissue samples were available and low incidence of anatomic maturation failure, which decreased the statistical power to find associations between end points and IH. CONCLUSIONS: Pre-existing, postoperative, and change in IH over time were not associated with 2-stage AVF outcomes.
BACKGROUND: The contribution of intimal hyperplasia (IH) to arteriovenous fistula (AVF) failure is uncertain. This observational study assessed the relationship between pre-existing, postoperative, and change in IH over time and AVF outcomes. STUDY DESIGN: Prospective cohort study with longitudinal assessment of IH at the time of AVF creation (pre-existing) and transposition (postoperative). Patients were followed up for up to 3.3 years. SETTING & PARTICIPANTS: 96 patients from a single center who underwent AVF surgery initially planned as a 2-stage procedure. Veins and AVF samples were collected from 66 and 86 patients, respectively. Matched-pair tissues were available from 56 of these patients. PREDICTORS: Pre-existing, postoperative, and change in IH over time. OUTCOMES: Anatomic maturation failure was defined as an AVF that never reached a diameter > 6mm. Primary unassisted patency was defined as the time elapsed from the second-stage surgery to the first intervention. MEASUREMENTS: Maximal intimal thickness in veins and AVFs and change in intimal thickness over time. RESULTS: Pre-existing IH (>0.05mm) was present in 98% of patients. In this group, the median intimal thickness increased 4.40-fold (IQR, 2.17- to 4.94-fold) between AVF creation and transposition. However, this change was not associated with pre-existing thickness (r(2)=0.002; P=0.7). Ten of 96 (10%) AVFs never achieved maturation, whereas 70% of vascular accesses remained patent at the end of the observational period. Postoperative IH was not associated with anatomic maturation failure using univariate logistic regression. Pre-existing, postoperative, and change in IH over time had no effects on primary unassisted patency. LIMITATIONS: The small number of patients from whom longitudinal tissue samples were available and low incidence of anatomic maturation failure, which decreased the statistical power to find associations between end points and IH. CONCLUSIONS: Pre-existing, postoperative, and change in IH over time were not associated with 2-stage AVF outcomes.
Authors: Christopher D Owens; Nicole Wake; Ji Min Kim; Dirk Hentschel; Michael S Conte; Andres Schanzer Journal: J Vasc Access Date: 2010 Oct-Dec Impact factor: 2.283
Authors: Eddie Manning; Nikolaos Skartsis; Armando M Orta; Omaida C Velazquez; Zhao-Jun Liu; Arif Asif; Loay H Salman; Roberto I Vazquez-Padron Journal: J Vasc Res Date: 2012-01-13 Impact factor: 1.934
Authors: Tonia C Rothuizen; Chunyu Wong; Paul H A Quax; Anton Jan van Zonneveld; Ton J Rabelink; Joris I Rotmans Journal: Nephrol Dial Transplant Date: 2013-03-29 Impact factor: 5.992
Authors: Ada W Y Chung; Pooja Rauniyar; Honglin Luo; York N Hsiang; Cornelis van Breemen; Elena B Okon Journal: J Vasc Surg Date: 2005-10 Impact factor: 4.268
Authors: Rajiv Saran; Yi Li; Bruce Robinson; John Ayanian; Rajesh Balkrishnan; Jennifer Bragg-Gresham; Joline T L Chen; Elizabeth Cope; Debbie Gipson; Kevin He; William Herman; Michael Heung; Richard A Hirth; Steven S Jacobsen; Kamyar Kalantar-Zadeh; Csaba P Kovesdy; Alan B Leichtman; Yee Lu; Miklos Z Molnar; Hal Morgenstern; Brahmajee Nallamothu; Ann M O'Hare; Ronald Pisoni; Brett Plattner; Friedrich K Port; Panduranga Rao; Connie M Rhee; Douglas E Schaubel; David T Selewski; Vahakn Shahinian; John J Sim; Peter Song; Elani Streja; Manjula Kurella Tamura; Francesca Tentori; Paul W Eggers; Lawrence Y C Agodoa; Kevin C Abbott Journal: Am J Kidney Dis Date: 2015-07 Impact factor: 8.860
Authors: Scott A Berceli; Zhihua Jiang; Nina V Klingman; Chun L Pfahnl; Zaher S Abouhamze; Constanza D Frase; Gregory S Schultz; C Keith Ozaki Journal: J Vasc Surg Date: 2004-05 Impact factor: 4.268
Authors: M Alexandra Monroy; Jianhua Fang; Shan Li; Lucas Ferrer; Mark P Birkenbach; Iris J Lee; Hong Wang; Xiao-Feng Yang; Eric T Choi Journal: Front Biosci (Landmark Ed) Date: 2015-01-01
Authors: Juan C Duque; Marwan Tabbara; Laisel Martinez; Jose Cardona; Roberto I Vazquez-Padron; Loay H Salman Journal: Am J Kidney Dis Date: 2016-10-27 Impact factor: 8.860
Authors: Alfred K Cheung; Peter B Imrey; Charles E Alpers; Michelle L Robbin; Milena Radeva; Brett Larive; Yan-Ting Shiu; Michael Allon; Laura M Dember; Tom Greene; Jonathan Himmelfarb; Prabir Roy-Chaudhury; Christi M Terry; Miguel A Vazquez; John W Kusek; Harold I Feldman Journal: J Am Soc Nephrol Date: 2017-07-14 Impact factor: 10.121
Authors: Michael Allon; Silvio H Litovsky; Yingying Zhang; Ha Le; Alfred K Cheung; Yan-Ting Shiu Journal: Clin J Am Soc Nephrol Date: 2018-08-23 Impact factor: 8.237
Authors: Laisel Martinez; Juan C Duque; Marwan Tabbara; Angela Paez; Guillermo Selman; Diana R Hernandez; Chad A Sundberg; Jason Chieh Sheng Tey; Yan-Ting Shiu; Alfred K Cheung; Michael Allon; Omaida C Velazquez; Loay H Salman; Roberto I Vazquez-Padron Journal: J Am Soc Nephrol Date: 2018-01-02 Impact factor: 10.121
Authors: Ke Wang; Leila R Zelnick; Peter B Imrey; Ian H deBoer; Jonathan Himmelfarb; Michael D Allon; Alfred K Cheung; Laura M Dember; Prabir Roy-Chaudhury; Miguel A Vazquez; John W Kusek; Harold I Feldman; Gerald J Beck; Bryan Kestenbaum Journal: Am J Nephrol Date: 2018-08-02 Impact factor: 3.754
Authors: Jie Cui; Chase W Kessinger; Harkamal S Jhajj; Madeleine S Grau; Sanjay Misra; Peter Libby; Jason R McCarthy; Farouc A Jaffer Journal: J Am Soc Nephrol Date: 2020-03-09 Impact factor: 10.121
Authors: Juan C Duque; Marwan Tabbara; Laisel Martinez; Angela Paez; Guillermo Selman; Loay H Salman; Omaida C Velazquez; Roberto I Vazquez-Padron Journal: Surgery Date: 2017-12-11 Impact factor: 3.982